Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Mayne Pharma Group ( (AU:MYX) ).
Mitsubishi UFJ Financial Group, Inc. has increased its voting power in Mayne Pharma Group Limited, with a notable change in the number of fully paid ordinary shares held by the financial group. This adjustment in shareholding reflects a strategic move by Mitsubishi UFJ Financial Group, Inc. to strengthen its influence within Mayne Pharma Group Limited, potentially impacting the company’s governance and stakeholder dynamics.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 980,618
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$429.8M
See more data about MYX stock on TipRanks’ Stock Analysis page.